ย 
Search

IDCARE TEAM LAND AT ECCMID 2022


๐—ฆ๐—ฒ๐—น๐—ฒ๐—ฐ๐˜๐—ฒ๐—ฑ ๐—บ๐—ฒ๐—บ๐—ฏ๐—ฒ๐—ฟ๐˜€ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐—œ๐——๐—–๐—ฎ๐—ฟ๐—ฒ ๐—ง๐—ฒ๐—ฎ๐—บ ๐˜„๐—ถ๐—น๐—น ๐—ฟ๐—ฒ๐—ฝ๐—ฟ๐—ฒ๐˜€๐—ฒ๐—ป๐˜ ๐˜๐—ต๐—ฒ ๐—จ๐—ป๐—ถ๐˜ƒ๐—ฒ๐—ฟ๐˜€๐—ถ๐˜๐˜† ๐—ผ๐—ณ ๐—ฉ๐—ฒ๐—ฟ๐—ผ๐—ป๐—ฎ ๐—ฎ๐˜ ๐˜๐—ต๐—ฒ ๐˜‚๐—ฝ๐—ฐ๐—ผ๐—บ๐—ถ๐—ป๐—ด ๐Ÿฏ๐Ÿฎ๐—ป๐—ฑ ๐—˜๐˜‚๐—ฟ๐—ผ๐—ฝ๐—ฒ๐—ฎ๐—ป ๐—–๐—ผ๐—ป๐—ด๐—ฟ๐—ฒ๐˜€๐˜€ ๐—ผ๐—ณ ๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐— ๐—ถ๐—ฐ๐—ฟ๐—ผ๐—ฏ๐—ถ๐—ผ๐—น๐—ผ๐—ด๐˜† & ๐—œ๐—ป๐—ณ๐—ฒ๐—ฐ๐˜๐—ถ๐—ผ๐˜‚๐˜€ ๐——๐—ถ๐˜€๐—ฒ๐—ฎ๐˜€๐—ฒ๐˜€.



The Congress will take place in Lisbon, Portugal from April 23-26, for the first time as a hybrid event both onsite and online. Our ID-Care Experts will present their latest findings, guidelines and experiences to an audience of over 14,000 colleagues in a comprehensive scientific and educational programme incorporating Keynote Lectures and Oral Sessions, as well as Educational Workshops, Open Forums, etc. ๐Ÿฎ๐Ÿฏ ๐—”๐—ฃ๐—ฅ๐—œ๐—Ÿ

The first appointment on 23th April is the Session dedicated COVID-19 in special populations Hall M at 11:00 ( Chair/Interviewer/Moderators/Expert Nicoloas Muelle, Switzerland โ€“ Cristina Oprea, Romania) when Dr ๐—”๐—ป๐—ป๐—ฎ ๐— ๐—ฎ๐—ฟ๐—ถ๐—ฎ ๐—”๐˜‡๐˜‡๐—ถ๐—ป๐—ถ will present:

๐—ฃ๐—ฟ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐˜๐—ผ๐—ฟ๐˜€ ๐—ผ๐—ณ ๐—ฐ๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฒ๐˜ƒ๐—ผ๐—น๐˜‚๐˜๐—ถ๐—ผ๐—ป ๐—ผ๐—ณ ๐—ฆ๐—”๐—ฅ๐—ฆ-๐—–๐—ผ๐—ฉ-๐Ÿฎ ๐—ถ๐—ป๐—ณ๐—ฒ๐—ฐ๐˜๐—ถ๐—ผ๐—ป ๐—ถ๐—ป ๐—ต๐—ฎ๐—ฒ๐—บ๐—ฎ๐˜๐—ผ๐—น๐—ผ๐—ด๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฝ๐—ฎ๐˜๐—ถ๐—ฒ๐—ป๐˜๐˜€: ๐—ฎ ๐˜€๐˜†๐˜€๐˜๐—ฒ๐—บ๐—ฎ๐˜๐—ถ๐—ฐ ๐—ฟ๐—ฒ๐˜ƒ๐—ถ๐—ฒ๐˜„ ๐—ฎ๐—ป๐—ฑ ๐—บ๐—ฒ๐˜๐—ฎ-๐—ฎ๐—ป๐—ฎ๐—น๐˜†๐˜€๐—ถ๐˜€.

At 14:00 Dr. ๐—™๐—ฎ๐—ฏ๐—ถ๐—ฎ๐—ป๐—ฎ ๐—”๐—ฟ๐—ถ๐—ฒ๐˜๐—ถ, in Room Fernando Pessa 2, will present ๐—˜๐—ฃ๐—œ-๐—ก๐—ฒ๐˜ - ๐—˜๐—ฝ๐—ถ๐—ฑ๐—ฒ๐—บ๐—ถ๐—ผ๐—น๐—ผ๐—ด๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฆ๐—ฒ๐—ฟ๐˜ƒ๐—ถ๐—ฐ๐—ฒ๐˜€ the European Clinical Research Alliance on Infectious Diseases (Ecraid).

๐Ÿฎ๐Ÿฐ ๐—”๐—ฃ๐—ฅ๐—œ๐—Ÿ

On 24th of April in Hall J at 8:30, Professor๐—˜๐˜ƒ๐—ฒ๐—น๐—ถ๐—ป๐—ฎ ๐—ง๐—ฎ๐—ฐ๐—ฐ๐—ผ๐—ป๐—ฒ๐—น๐—น๐—ถ for the session โ€œSupporting evidence in infection prevention and control: 2022 Escmid guidelinesโ€, will present

๐—ฆ๐˜‚๐—ฟ๐—ด๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฝ๐—ฟ๐—ผ๐—ฝ๐—ต๐˜†๐—น๐—ฎ๐˜…๐—ถ๐˜€ ๐—ถ๐—ป ๐—ฝ๐—ฎ๐˜๐—ถ๐—ฒ๐—ป๐˜๐˜€ ๐—ฐ๐—ผ๐—น๐—ผ๐—ป๐—ถ๐˜€๐—ฒ๐—ฑ ๐˜„๐—ถ๐˜๐—ต ๐—บ๐˜‚๐—น๐˜๐—ถ๐—ฑ๐—ฟ๐˜‚๐—ด ๐—ฟ๐—ฒ๐˜€๐—ถ๐˜€๐˜๐—ฎ๐—ป๐˜ ๐—š๐—ฟ๐—ฎ๐—บ-๐—ป๐—ฒ๐—ด๐—ฎ๐˜๐—ถ๐˜ƒ๐—ฒ๐˜€.

The aim of this session is to present the new ECMID guidelines in the field of IPC that are currently under development or recently published introducing the audience to the brand new evidence on IPC. At 11:00 in Hall E, Dr. ๐—˜๐—น๐—ฒ๐—ป๐—ฎ ๐—–๐—ฎ๐—ฟ๐—ฟ๐—ฎ๐—ฟ๐—ฎ in one- hour Session โ€œ ๐—ฌ๐—ฒ๐—ฎ๐—ฟ ๐—ถ๐—ป ๐—œ๐—ป๐—ณ๐—ฒ๐—ฐ๐˜๐—ถ๐—ผ๐˜‚๐˜€ ๐——๐—ถ๐˜€๐—ฒ๐—ฎ๐˜€๐—ฒ๐˜€ โ€ will review the most recent and interesting literature on the topic together with Dr Joanne M. Langley

๐Ÿฎ๐Ÿฑ ๐—”๐—ฃ๐—ฅ๐—œ๐—Ÿ is a full day for our Team in ECCMID. Dr ๐—˜๐—น๐—ฒ๐—ป๐—ฎ ๐—–๐—ฎ๐—ฟ๐—ฟ๐—ฎ๐—ฟ๐—ฎ will start at 8:30 in Hall J, during the Session of Escmid Guidelines for the treatment of infection caused by multidrug-resistant Gram-negatives, presenting ๐—–๐—ฎ๐˜€๐—ฒ๐˜€ ๐—ผ๐—ณ ๐—บ๐˜‚๐—น๐˜๐—ถ๐—ฑ๐—ฟ๐˜‚๐—ด-๐—ฟ๐—ฒ๐˜€๐—ถ๐˜€๐˜๐—ฎ๐—ป๐˜ and providing the opportunity to review the evidence and present the recommendations in the Guidelines.

At 9:00 in Room Fernando Pessa 2 of Altice Arena, Dr ๐—™๐—ฎ๐—ฏ๐—ถ๐—ฎ๐—ป๐—ฎ ๐—”๐—ฟ๐—ถ๐—ฒ๐˜๐—ถ will take part in the Young Investigator Workshop presenting ๐˜๐—ต๐—ฒ ๐—ฟ๐—ผ๐—น๐—ฒ ๐—ผ๐—ณ ๐—˜๐—ฃ๐—œ โ€“๐—ก๐—ฒ๐˜ ๐—ถ๐—ป ๐˜๐—ต๐—ฒ ๐—˜๐—ฐ๐—ฟ๐—ฎ๐—ถ๐—ฑ ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐—”๐—น๐—น๐—ถ๐—ฎ๐—ป๐—ฐ๐—ฒ. At 11:00 In Hall A, Professor ๐—˜๐˜ƒ๐—ฒ๐—น๐—ถ๐—ป๐—ฎ ๐—ง๐—ฎ๐—ฐ๐—ฐ๐—ผ๐—ป๐—ฒ๐—น๐—น๐—ถ, as Keynote Lecturer, will be interviewed by Leonard LIebovici, Israel on the ๐—”๐—ฑ๐˜ƒ๐—ฎ๐—ป๐—ฐ๐—ฒ๐˜€ ๐—ถ๐—ป ๐—ฐ๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฎ๐—ป๐˜๐—ถ๐—ฏ๐—ฎ๐—ฐ๐˜๐—ฒ๐—ฟ๐—ถ๐—ฎ๐—น ๐—ฟ๐—ฒ๐˜€๐—ถ๐˜€๐˜๐—ฎ๐—ป๐—ฐ๐—ฒ ๐—ฟ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต.

And last but not least, in Hall K at 14:45 during the session โ€œAntibiotic stewardship in hospitals and primary careโ€, Dr ๐— ๐—ฎ๐—ฟ๐—ถ๐—ฎ ๐——๐—ถ๐—น๐—ฒ๐˜๐˜๐—ฎ ๐—ฃ๐—ฒ๐˜‡๐˜‡๐—ฎ๐—ป๐—ถ will speak about ๐— ๐˜‚๐—น๐˜๐—ถ๐˜€๐—ฒ๐—ฐ๐˜๐—ผ๐—ฟ๐—ฎ๐—น ๐—ฎ๐—ป๐˜๐—ถ๐—บ๐—ถ๐—ฐ๐—ฟ๐—ผ๐—ฏ๐—ถ๐—ฎ๐—น ๐—ฐ๐—ผ๐—ป๐˜€๐˜‚๐—บ๐—ฝ๐˜๐—ถ๐—ผ๐—ป ๐—ฎ๐—ป๐—ฑ ๐—ฟ๐—ฒ๐˜€๐—ถ๐˜€๐˜๐—ฎ๐—ป๐—ฐ๐—ฒ ๐˜€๐˜‚๐—ฟ๐˜ƒ๐—ฒ๐—ถ๐—น๐—น๐—ฎ๐—ป๐—ฐ๐—ฒ ๐—ฑ๐—ฎ๐˜๐—ฎ ๐—ฟ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜๐—ถ๐—ป๐—ด ๐˜๐—ผ ๐—ถ๐—ป๐—ณ๐—ผ๐—ฟ๐—บ ๐—ฎ๐—ป๐˜๐—ถ๐—ฏ๐—ถ๐—ผ๐˜๐—ถ๐—ฐ ๐—ฝ๐—ผ๐—น๐—ถ๐—ฐ๐—ถ๐—ฒ๐˜€ ๐—ถ๐—ป ๐—ต๐˜‚๐—บ๐—ฎ๐—ป ๐˜€๐—ฒ๐—ฐ๐˜๐—ผ๐—ฟ: ๐˜๐—ต๐—ฒ ๐—˜๐—ฃ๐—œ-๐—ก๐—ฒ๐˜ ๐—ฒ๐˜…๐—ฝ๐—ฒ๐—ฟ๐—ถ๐—ฒ๐—ป๐—ฐ๐—ฒ.


๐—ฆ๐—”๐—ฉ๐—˜ ๐—”๐—Ÿ๐—Ÿ ๐——๐—”๐—ง๐—˜๐—ฆ ๐—”๐—ก๐—— ๐—ž๐—˜๐—˜๐—ฃ ๐—œ๐—ก ๐—ง๐—ข๐—จ๐—–๐—›!



ย